{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:07:52Z","timestamp":1787969272867,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.jcv.2010.07.014","type":"journal-article","created":{"date-parts":[[2010,8,22]],"date-time":"2010-08-22T08:47:59Z","timestamp":1282466879000},"page":"163-168","source":"Crossref","is-referenced-by-count":75,"title":["Risk of fetal hydrops and non-hydropic late intrauterine fetal death after gestational parvovirus B19 infection"],"prefix":"10.1016","volume":"49","author":[{"given":"Martin","family":"Enders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Klingel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Weidner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Baisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Kandolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Schalasta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Enders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2010.07.014_bib0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1017\/S0965539505001518","article-title":"Parvovirus B19 infection in pregnancy","volume":"16","author":"Cohen","year":"2005","journal-title":"Fetal Matern Med Rev"},{"key":"10.1016\/j.jcv.2010.07.014_bib0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/j.1600-0412.2000.079001015.x","article-title":"Etiology and outcome of second trimester non-immunologic fetal hydrops","volume":"79","author":"Heinonen","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jcv.2010.07.014_bib0015","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/uog.1009","article-title":"Fetal middle cerebral artery peak systolic velocity in the investigation of non-immune hydrops","volume":"23","author":"Hernandez-Andrade","year":"2004","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jcv.2010.07.014_bib0020","first-page":"36","article-title":"Human B19 parvovirus infection in an obstetric population. A prospective study determining fetal outcome","volume":"39","author":"Guidozzi","year":"1994","journal-title":"J Reprod Med"},{"key":"10.1016\/j.jcv.2010.07.014_bib0025","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/infdis\/171.5.1360","article-title":"The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome","volume":"171","author":"Gratac\u00f3s","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2010.07.014_bib0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0029-7844(97)00701-1","article-title":"Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms","volume":"91","author":"Harger","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jcv.2010.07.014_bib0035","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00006454-199806000-00011","article-title":"Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy","volume":"17","author":"Koch","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jcv.2010.07.014_bib0040","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1471-0528.1998.tb10048.x","article-title":"Immediate and long term outcome of human parvovirus B19 infection in pregnancy","volume":"105","author":"Miller","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jcv.2010.07.014_bib0045","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/pd.940","article-title":"Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases","volume":"24","author":"Enders","year":"2004","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jcv.2010.07.014_bib0050","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1620\/tjem.209.277","article-title":"Clinical manifestations and outcomes of parvovirus B19 infection during pregnancy in Japan","volume":"209","author":"Chisaka","year":"2006","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.jcv.2010.07.014_bib0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ajcp\/96.1.121","article-title":"Parvovirus B19 infection of the fetus. Histology and in situ hybridization","volume":"96","author":"Schwarz","year":"1991","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jcv.2010.07.014_bib0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1471-0528.1996.tb09664.x","article-title":"Fetal pathology in intrauterine death due to parvovirus B19 infection","volume":"103","author":"Wright","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jcv.2010.07.014_bib0065","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0140-6736(00)04647-X","article-title":"Frequency of human parvovirus B19 infection in intrauterine fetal death","volume":"357","author":"Tolfvenstam","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2010.07.014_bib0070","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1086\/342575","article-title":"Revised clinical presentation of parvovirus B19-associated intrauterine fetal death","volume":"35","author":"Norbeck","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcv.2010.07.014_bib0075","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1086\/593190","article-title":"Parvovirus b19 infection in fetal deaths","volume":"47","author":"Riipinen","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcv.2010.07.014_bib0080","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1017\/S095026880600731X","article-title":"Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany","volume":"135","author":"Enders","year":"2007","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jcv.2010.07.014_bib0085","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jmv.1890350207","article-title":"Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum","volume":"35","author":"Erdman","year":"1991","journal-title":"J Med Virol"},{"key":"10.1016\/j.jcv.2010.07.014_bib0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jmv.1019","article-title":"Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins","volume":"64","author":"Manaresi","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/j.jcv.2010.07.014_bib0095","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jcv.2005.11.002","article-title":"Human parvovirus B19 infection during pregnancy\u2014value of modern molecular and serological diagnostics","volume":"35","author":"Enders","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2010.07.014_bib0100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jviromet.2007.08.008","article-title":"Comparative evaluation of two commercial enzyme immunoassays for serodiagnosis of human parvovirus B19 infection","volume":"146","author":"Enders","year":"2007","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jcv.2010.07.014_bib0105","volume":"vol. 1","author":"World Health Organization (WHO)","year":"1992"},{"key":"10.1016\/j.jcv.2010.07.014_bib0110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0166-0934(00)00227-5","article-title":"Detection of parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristic analysis","volume":"90","author":"Doyle","year":"2000","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jcv.2010.07.014_bib0115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02771838","article-title":"Acute parvovirus B19 infection in pregnant women--an analysis of serial samples by serological and semi-quantitative PCR techniques","volume":"26","author":"Searle","year":"1998","journal-title":"Infection"},{"key":"10.1016\/j.jcv.2010.07.014_bib0120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jmv.20049","article-title":"LightCycler consensus PCR for rapid and differential detection of human erythrovirus B19 and V9 isolates","volume":"73","author":"Schalasta","year":"2004","journal-title":"J Med Virol"},{"key":"10.1016\/j.jcv.2010.07.014_bib0125","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1073\/pnas.89.1.314","article-title":"Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation","volume":"89","author":"Klingel","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcv.2010.07.014_bib0130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1053\/hupa.2003.48","article-title":"Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease","volume":"34","author":"B\u00fcltmann","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jcv.2010.07.014_bib0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0166-0934(95)00040-2","article-title":"Evaluation of 4 commercial test kits for parvovirus B19-specific IgM","volume":"55","author":"Cohen","year":"1995","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jcv.2010.07.014_bib0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0888-0786(96)80010-2","article-title":"Comparative evaluation of commercial methods for the detection of parvovirus B19-specific immunoglobulin M","volume":"8","author":"de Ory","year":"1996","journal-title":"Serodiagn Immunother Infect Dis"},{"key":"10.1016\/j.jcv.2010.07.014_bib0145","doi-asserted-by":"crossref","first-page":"524601","DOI":"10.1155\/2008\/524601","article-title":"High rate of severe fetal outcomes associated with maternal parvovirus b19 infection in pregnancy","volume":"2008","author":"Beigi","year":"2008","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.jcv.2010.07.014_bib0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000236149","article-title":"Management and outcome of pregnancies with parvovirus B19 infection over seven years in a tertiary fetal medicine unit","volume":"25","author":"Simms","year":"2009","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.jcv.2010.07.014_bib0155","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0163-4453(99)90026-9","article-title":"Serologic study of human parvovirus B19 infection in pregnancy in Japan","volume":"38","author":"Yaegashi","year":"1999","journal-title":"J Infect"},{"key":"10.1016\/j.jcv.2010.07.014_bib0160","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(95)92346-2","article-title":"Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection","volume":"346","author":"Fairley","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jcv.2010.07.014_bib0165","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0002-9378(98)70203-0","article-title":"Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of the Society of Perinatal Obstetricians","volume":"179","author":"Rodis","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jcv.2010.07.014_bib0170","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1046\/j.1469-0705.2001.00471.x","article-title":"Fetal parvovirus B19 infection","volume":"18","author":"von Kaisenberg","year":"2001","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jcv.2010.07.014_bib0175","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/j.1471-0528.2009.02211.x","article-title":"Maternal human parvovirus B19 infection and the risk of fetal death and low birthweight: a case-control study within 35 940 pregnant women","volume":"116","author":"Sarfraz","year":"2009","journal-title":"BJOG"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653210003033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653210003033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T16:51:28Z","timestamp":1544287888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653210003033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S1386653210003033"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2010.07.014","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}